MemoryPlus is pioneering an innovative treatment
targeting Alzheimer’s-related cognitive decline,
leveraging a novel mechanism of action (MOA). Our
research is based on groundbreaking work from Prof.
Shira Knafo, who discovered that the PTEN protein
plays a critical role in memory decline by inhibiting
neuronal activity. By disrupting the interaction
between PTEN and PDZ domain proteins, we have the
potential to restore memory function.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Memoryplus.biz Questions
Memoryplus.Biz's LinkedIn profile is https://www.linkedin.com/company/memoryplus-biz
Memoryplus.Biz has
1 employees.
View email and phone details for 1
employees at Memoryplus.Biz.
Memoryplus.Biz's industry is
Biotechnology Research
Memoryplus.Biz's top competitors are
Alveron Pharma,
Fvmat,
Bri - Battery Recycling Israel,
Memory Plus,
Nasus Pharma,
Synerkine Pharma,
Se-Cure Pharmaceuticals Ltd.,
Dio Tree,
Amalus Therapeutics,
Orexa B.v..
Memoryplus.Biz's categories are Biotechnology Research
Memoryplus.Biz's founding year is 2019
